Something we’ve been working on internally this year is using various bottoms-up tools and scans to complement our top-down approach. One way we’re doing...
Well, Nifty 50 is really not interested in that statement because it continues to remain messy. But in this messy move, we've seen certain sectors outperform the others. One among the outperformers is the ...
We've been talking about this for a long time: this year is NOT last year.
The things that worked for the last 3 quarters of 2020 are not working in 2021. Stocks are a mess. Growth is a massive underperformer. Small-caps can't stop churning...
This week we're looking at two long setups in the Pharma sector. With Nifty Pharma breaking out above its resistance of 13,500, a couple of stocks that we've been tracking for quite some time now have also followed through with a breakout.
Dividend aristocrats are easily some of the most desirable investments on Wall Street. These are the names that have increased dividends for at least 25 years, providing steadily increasing...
Anybody who has been tracking the market closely has noticed that the one sector which has been displaying the most strength off late is Metals. The sector-specific stocks have generated handsome returns in a short span of time and don't seem to be...